Gopar-Nieto R, Rivas-Lasarte M, Moya-Álvarez A, García-Cruz E, Manzur-Sandoval D, Arias-Mendoza A, Sierra-Lara Martínez D, Araiza-Garaygordobil D

Language: Spanish
References: 14
Page: 178-181
PDF size: 221.35 Kb.

ABSTRACT

The SARS-CoV-2 infection has as a clinical manifestation the disease known as COVID-19. Although knowledge of the nature of the disease is dynamic, with dozens of scientific articles being published every day about new features of COVID-19, the typical presentation is that of interstitial pneumonia. Despite the large amount of information that has been developed in recent weeks, it has been estimated that this disease can have up to 72% underdiagnosis, which requires clinical tools that are simple, easily accessible, and increase the detection of cases in a feasible way and that yield information with prognostic value. Given this need, some proposals have emerged to be able to diagnose, monitor and respond to the treatment of patients with COVID-19, such as pulmonary ultrasound (USP). It is worth mentioning that the USP has proven to be an efficient and easily reproducible technique for diagnosing heart failure and pleuro-pulmonary pathologies, especially in critically ill patients. Evidence of the usefulness of USP in COVID-19 is still scarce, although preliminary, it seems to be a sensitive technique whose findings have a high gold standard. In this brief review we will emphasize its technical aspects, the advantages and disadvantages, and finally a proposal for the approach in this type of patient.

REFERENCES

1. Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SL et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020; 395 (10228): 949-950.

2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of coronavirus dis-ease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.

3. Tuite AR, Ng C, Rees E, Fisman D. Estimation of COVID-19 outbreak size in Italy. Lancet Infect Dis. 2020; 20 (5): 537.

4. Lichtenstein DA. The probe. In: Lichtenstein DA. Lung ultrasound in the critically ill. The BLUE Protocol. Heidelberg, Alemania: Springer; 2016. pp. 23-35.

5. Lichtenstein D, Méziére G. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008; 134: 117-125.

6. Gopar-Nieto R, Alanís-Estrada GP, Ronquillo-Ramírez DE, Vargas-Estrada JL, Arias-Mendoza A, Rojas-Velasco G et al. El ultrasonido pulmonar en cardiología: realidades y promesas. Arch Cardiol Mex. 2019; 89: 369-375.

7. Poggiali E, Dacrema A, Bastoni D, Tinelli V, Demichele E, Mateo-Ramos P et al. Can Lung US help critical care clinicians in the early diagnosis of novel coronavirus (COVID-19) pneumonia? Radiology. 2020: 295 (3) E6.

8. Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF et al. Is there a role for lung ultrasound during the COVID-19 pandemic? J Ultrasound Med. 2020. 10.1002/jum.15284. [Epub ahead of print]

9. Smith MJ, Hayward SA, Innes SM, Miller ASC. Point-of-care lung ultrasound in patients with COVID-19 - a narrative review [published online ahead of print, 2020 Apr 10]. Anaesthesia. 2020. doi: 10.1111/anae.15082.

10. Moro F, Buonsenso D, Moruzzi MC, Inchingolo R, Smargiassi A, Demi L et al. How to perform lung ultrasound in pregnant women with suspected COVID-19. Ultrasound Obstet Gynecol. 2020; 55 (5): 593-598.

11. Kalafat E, Yaprak E, Cinar G, Varli B, Ozisik S, Uzun C et al. Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19. Ultrasound Obstet Gynecol. 2020; 55 (6): 835-837. doi: 10.1002/uog.22034.

12. van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382 (16): 1564-1567. doi: 10.1056/NEJMc2004973.

13. Buonsenso D, Pata D, Chiaretti A. COVID-19 outbreak: less stethoscope, more ultrasound. Lancet Respir Med. 2020; 8 (5): e27. doi: 10.1016/S2213-2600(20)30120-X.

14. Buonsenso D, Piano A, Raffaelli F, Bonadia N, de Gaetano Donati K, Franceschi F. Point-of-care lung ultrasound findings in novel coronavirus disease-19 pneumoniae: a case report and potential applications during COVID-19 outbreak. Eur Rev Med Pharmacol Sci. 2020; 24: 2776-2780.